Anemia Development and Cardiovascular Risk Management in Nonanemic Stage 3 Chronic Kidney Disease

REFERENCES

• Sarnak MJ, Levey AS, Schoolwerth AC, Kidney disease as a risk factor for development of cardiovascular disease: A statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Hypertension. 2003;42:1050–1065.
   PubMed Web of Science ®Google Scholar
• García de Vinuesa S. Progression factors for chronic kidney disease. Secondary prevention. Nefrología. 2008;28(Suppl. 3):17–21.
   PubMedGoogle Scholar
• Portolés J, Lopez JM, Aljama P, Tato A. CV risk in HD in Spain: Prevalence, management and target results (MAR Study). Nefrología. 2005;24:83–92.
   Google Scholar
• Eschbach J, Adamson J. Anaemia of end-stage renal disease (ESDR). Kidney Int. 1985;28:1–5.
   PubMed Web of Science ®Google Scholar
• Eschbach J. The anaemia of chronic renal failure: Pathophysiology and the effects of recombinant erythropoietin. Kidney Int. 1989;35:134–148.
   PubMed Web of Science ®Google Scholar
• Astor BC, Muntner P, Levin A, Eustace JA, Coresh J. Association of kidney function with anaemia: The Third National Health and Nutrition Examination Survey (1988–1994). Arch Intern Med. 2002;162:1401–1408.
   PubMed Web of Science ®Google Scholar
• Locatelli F, Aljama P, Bárány P, European Best Practice Guidelines Working Group. Revised European best practice guidelines for the management of anaemia in patients with chronic renal failure. Nephrol Dial Transplant. 2004;19(Suppl. 2):1–47.
   PubMedGoogle Scholar
• Eschbach J. Current concepts of anaemia management in chronic renal failure: Impact of NKF-DOQI. Semin Nephrol. 2000;20:320–329.
   PubMedGoogle Scholar
• Moreno F, Valderrábano F. Treatment of anaemia with erythropoietin in chronic kidney disease. In: Llach F, Valderrábano F, ( eds.). Enfermedad renal crónica. Madrid: Norma;1997:449–474.
   Google Scholar
• Kazmi WH, Kausz AT, Kan S, Anemia: An early complication of chronic renal insufficiency. Am J Kidney Dis. 2001;38:803–812.
   PubMed Web of Science ®Google Scholar
• Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med. 1999;130:461–470.
   PubMed Web of Science ®Google Scholar
• Charlson M, Szatrowski TP, Peterson J, Gold J. Validation of a combined comorbidity index. J Clin Epidemiol. 1994;47:1245–1251.
   PubMed Web of Science ®Google Scholar
• Fried L, Bernardini J, Piraino B. Charlson comorbidity index as a predictor of outcomes in incident peritoneal dialysis patients. Am J Kidney Dis. 2001;37:337–342.
   PubMed Web of Science ®Google Scholar
• Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001;285:2486–2497.
   PubMed Web of Science ®Google Scholar
• American Diabetes Association. Standards of medical care for patients with diabetes mellitus (position statement). Diabetes Care. 2006;29:S4–S42.
   PubMed Web of Science ®Google Scholar
• De Nicola L, Minutolo R, Chiodini P, Target Blood Pressure Levels in Chronic Kidney Disease (TABLE in CKD) Study Group. Global approach to cardiovascular risk in chronic kidney disease: Reality and opportunities for intervention. Kidney Int. 2006;69:538–545.
   PubMedGoogle Scholar
• National Kidney Foundation. K/DOQI Clinical Practice Guidelines for Chronic Kidney Disease. Evaluation, Classification, and Stratification. http://www.kidney.org/professionals/KDOQI/ (October 31, 2008).
   Google Scholar
• Otero A, Gayoso P, Garcia F, de Francisco AL, on behalf of the EPIRCE Study Group. Epidemiology of chronic renal disease in the Galician population: Results of the pilot Spanish EPIRCE study. Kidney Int Suppl. 2005;99:S16–S19.
   Google Scholar
• Portolés J, López-Gómez JM, Aljama P. Anemia management and treatment response in patients on hemodialysis: The Mar Study. J Nephrology. 2006;19:352–360.
   PubMedGoogle Scholar
• Coresh J, Astor BC, Greene T, Eknoyan G, Levey A. Prevalence of chronic kidney disease and decreased kidney function in the adult U.S. population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis. 2003;41:1–12.
   PubMed Web of Science ®Google Scholar
• Portolés J, López-Gómez JM, Aljama P. A prospective study of the role of anaemia as a risk factor in HD patients. Nephrol Dial Transplant. 2007 22:500–507.
   PubMedGoogle Scholar
• Locatelli F, Pisoni RL, Combe C, Anaemia in hemodialysis patients of five European countries: Association with morbidity and mortality in DOPPS. Nephrol Dial Transplant. 2004;19:121–132.
   PubMed Web of Science ®Google Scholar
• Portolés J, Gorriz JL, Martinez-Castelao A, One-year mortality and risk factors management in diabetic vs. non-diabetic patients with chronic kidney disease stages 3 and 4: Merena Study. Nephrol Dial Transplant. 2007;21:393.
   Google Scholar
• Keith D, Nichols GA, Gullion CM, Betz JB, Smith DH. Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization. Arch Intern Med. 2004;164:659–663.
   PubMed Web of Science ®Google Scholar
• Llisterri JL, Rodríguez-Roca GC, Alonso FJ, Control of blood pressure in Spanish hypertensive population attended in primary health care. PRESCAP 2006 Study. Med Clin (Barc). 2008;130:681–687.
   PubMedGoogle Scholar
• Fontseré N, Bonal J, Torres F, de las Cuevas X, Fort J. Compliance with the 2002 consensus document of the Spanish Society of Nephrology for the control of diabetic nephropathy in Catalonia (ECCODIAB). Nefrologia. 2006:26:679–687.
   PubMedGoogle Scholar
• Chobanian AV, Bakris GL, Black HR, The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 Report. JAMA. 2003;289:2560–2572.
   PubMed Web of Science ®Google Scholar
• National Kidney Foundation. K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis. 2003;42(Suppl. 3):S1–S201.
   PubMed Web of Science ®Google Scholar
• Johnson DW, Craven AM, Isbel NM. Modification of cardiovascular risk in hemodialysis patients: An evidence-based review. Hemodial Int. 2007;11:1–14.
   PubMedGoogle Scholar